Dallas company gets $10M for chronic pain treatment
Friday, February 26, 2010
DBJ
MicroTransponder Inc. has received nearly $10
million to help it conduct clinical trials to develop a wireless
neurotransmitter that treats chronic pain.
The Dallas-based medical device startup, which is a University
of Texas at Dallas spin-out company, finalized a $7 million funding
deal last week from several Texas-based angel investors, and it
will receive $2.6 million from a National Institutes of Health
grant, said Jordan Curnes, MicroTransponder's president and chief
operating officer. Curnes declined to release the investors'
names.
To read the entire story click
here.